2012-09-14
| Signal | Price | Bias | Subject | Owned |
|---|---|---|---|---|
| HOLD | $68.270 | DEFENSIVE | GLOBAL | No |
They are going to split off their medical device and their pharmaceutical division. This is in kind of a Hold mode right now until the split comes through. This is a company that has raised its dividend historically. Free cash flow is a very good. When the split comes, hang on to both shares. You’ll probably see your average cost base cut in half.
David Driscoll
Partner,
Toron Investment Management